| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 9.32e-05 | 44 | 40 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 1.74e-04 | 10 | 40 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.74e-04 | 10 | 40 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 3.87e-04 | 71 | 40 | 3 | GO:0042054 | |
| GeneOntologyMolecularFunction | amino acid binding | 4.20e-04 | 73 | 40 | 3 | GO:0016597 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 7.27e-04 | 20 | 40 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | 1.03e-03 | 224 | 40 | 4 | GO:0016741 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.11e-03 | 229 | 40 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | opsonin binding | 1.14e-03 | 25 | 40 | 2 | GO:0001846 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 1.15e-03 | 103 | 40 | 3 | GO:0008276 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 1.21e-03 | 105 | 40 | 3 | GO:0008170 | |
| GeneOntologyMolecularFunction | complement binding | 1.87e-03 | 32 | 40 | 2 | GO:0001848 | |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 3.05e-03 | 41 | 40 | 2 | GO:0140463 | |
| GeneOntologyMolecularFunction | small GTPase binding | 3.80e-03 | 321 | 40 | 4 | GO:0031267 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 4.91e-03 | 172 | 40 | 3 | GO:0008757 | |
| GeneOntologyMolecularFunction | Hsp90 protein binding | 5.43e-03 | 55 | 40 | 2 | GO:0051879 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 5.57e-03 | 180 | 40 | 3 | GO:0004866 | |
| GeneOntologyMolecularFunction | GTPase binding | 5.69e-03 | 360 | 40 | 4 | GO:0051020 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 6.19e-03 | 187 | 40 | 3 | GO:0030414 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 7.55e-03 | 201 | 40 | 3 | GO:0061135 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 8.20e-03 | 68 | 40 | 2 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 8.43e-03 | 69 | 40 | 2 | GO:0016278 | |
| GeneOntologyMolecularFunction | methyltransferase activity | 8.85e-03 | 213 | 40 | 3 | GO:0008168 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 9.65e-03 | 74 | 40 | 2 | GO:0016782 | |
| GeneOntologyCellularComponent | symbiont cell surface | 9.92e-05 | 8 | 40 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 1.27e-04 | 9 | 40 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | terminal bouton | 8.20e-04 | 96 | 40 | 3 | GO:0043195 | |
| GeneOntologyCellularComponent | neuronal cell body | 9.32e-04 | 835 | 40 | 7 | GO:0043025 | |
| Domain | Anaphylatoxin_comp_syst | 4.45e-05 | 5 | 40 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 4.45e-05 | 5 | 40 | 2 | IPR001840 | |
| Domain | ANATO | 9.33e-05 | 7 | 40 | 2 | SM00104 | |
| Domain | ANATO | 9.33e-05 | 7 | 40 | 2 | PF01821 | |
| Domain | ANAPHYLATOXIN_2 | 9.33e-05 | 7 | 40 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 9.33e-05 | 7 | 40 | 2 | PS01177 | |
| Domain | Anaphylatoxin/fibulin | 9.33e-05 | 7 | 40 | 2 | IPR000020 | |
| Domain | Thiol-ester_cl | 1.24e-04 | 8 | 40 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.24e-04 | 8 | 40 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 1.24e-04 | 8 | 40 | 2 | IPR019742 | |
| Domain | A2M_N | 1.99e-04 | 10 | 40 | 2 | PF01835 | |
| Domain | A2M_N | 1.99e-04 | 10 | 40 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.99e-04 | 10 | 40 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.99e-04 | 10 | 40 | 2 | PS00477 | |
| Domain | A2M | 1.99e-04 | 10 | 40 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.99e-04 | 10 | 40 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.99e-04 | 10 | 40 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 1.99e-04 | 10 | 40 | 2 | PF07703 | |
| Domain | A2M_recep | 1.99e-04 | 10 | 40 | 2 | PF07677 | |
| Domain | A2M_comp | 1.99e-04 | 10 | 40 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 1.99e-04 | 10 | 40 | 2 | IPR001599 | |
| Domain | C345C | 5.96e-04 | 17 | 40 | 2 | SM00643 | |
| Domain | Znf_PHD-finger | 6.43e-04 | 79 | 40 | 3 | IPR019787 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 6.70e-04 | 18 | 40 | 2 | IPR008930 | |
| Domain | NTR | 7.47e-04 | 19 | 40 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 7.47e-04 | 19 | 40 | 2 | IPR018933 | |
| Domain | PHD | 9.10e-04 | 89 | 40 | 3 | SM00249 | |
| Domain | Znf_PHD | 9.70e-04 | 91 | 40 | 3 | IPR001965 | |
| Domain | EPHD | 1.01e-03 | 22 | 40 | 2 | PS51805 | |
| Domain | ZF_PHD_2 | 1.10e-03 | 95 | 40 | 3 | PS50016 | |
| Domain | NTR | 1.10e-03 | 23 | 40 | 2 | PS50189 | |
| Domain | Netrin_domain | 1.10e-03 | 23 | 40 | 2 | IPR001134 | |
| Domain | ZF_PHD_1 | 1.13e-03 | 96 | 40 | 3 | PS01359 | |
| Domain | TIMP-like_OB-fold | 1.41e-03 | 26 | 40 | 2 | IPR008993 | |
| Domain | SET | 3.48e-03 | 41 | 40 | 2 | PF00856 | |
| Domain | Znf_FYVE_PHD | 3.81e-03 | 147 | 40 | 3 | IPR011011 | |
| Domain | SET | 4.36e-03 | 46 | 40 | 2 | SM00317 | |
| Domain | SET_dom | 5.13e-03 | 50 | 40 | 2 | IPR001214 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 1.11e-04 | 7 | 33 | 2 | MM14685 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 1.47e-04 | 8 | 33 | 2 | M27031 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 1.47e-04 | 8 | 33 | 2 | M47872 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 2.88e-04 | 11 | 33 | 2 | MM1430 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 2.88e-04 | 11 | 33 | 2 | M47874 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 3.46e-04 | 12 | 33 | 2 | MM1368 | |
| Pathway | WP_SIDS_SUSCEPTIBILITY_PATHWAYS | 3.47e-04 | 59 | 33 | 3 | MM15838 | |
| Pathway | WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS | 4.08e-04 | 13 | 33 | 2 | M39894 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 4.08e-04 | 13 | 33 | 2 | M4732 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 5.47e-04 | 15 | 33 | 2 | M7146 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 7.07e-04 | 17 | 33 | 2 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 7.07e-04 | 17 | 33 | 2 | MM1369 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 9.83e-04 | 20 | 33 | 2 | M917 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 1.19e-03 | 22 | 33 | 2 | M39502 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 1.29e-06 | 2 | 40 | 2 | 16565498 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 15998580 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 1.29e-06 | 2 | 40 | 2 | 25339671 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 17728371 | ||
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 1.29e-06 | 2 | 40 | 2 | 7373044 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 19062096 | ||
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 1.29e-06 | 2 | 40 | 2 | 3696167 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 6149580 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 6149581 | ||
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 1.29e-06 | 2 | 40 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 1.29e-06 | 2 | 40 | 2 | 16098595 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 1.29e-06 | 2 | 40 | 2 | 19933335 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 12115608 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 3542363 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 2387317 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 8132550 | ||
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 1.29e-06 | 2 | 40 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 1.29e-06 | 2 | 40 | 2 | 17645767 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 1.29e-06 | 2 | 40 | 2 | 15787745 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 12207352 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 2395880 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 26814708 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 6192448 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 6167582 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 16908004 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 30026462 | ||
| Pubmed | Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. | 1.29e-06 | 2 | 40 | 2 | 1438267 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 7365238 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 6559257 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 1.29e-06 | 2 | 40 | 2 | 27758680 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 19150565 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 7391573 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 17506029 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 22387014 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 17971360 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 1.29e-06 | 2 | 40 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 1.29e-06 | 2 | 40 | 2 | 20506482 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 23715124 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 3464002 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 2993295 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 1.29e-06 | 2 | 40 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 1.29e-06 | 2 | 40 | 2 | 17971229 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 12480675 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 6881182 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 26800705 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 1.29e-06 | 2 | 40 | 2 | 23749435 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 23918728 | ||
| Pubmed | Identification of the site of sulfation of the fourth component of human complement. | 1.29e-06 | 2 | 40 | 2 | 3944109 | |
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 1.29e-06 | 2 | 40 | 2 | 15390104 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 1.29e-06 | 2 | 40 | 2 | 3037333 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 11726230 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 4216347 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 1.29e-06 | 2 | 40 | 2 | 17921792 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 21880985 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 1.29e-06 | 2 | 40 | 2 | 1699796 | |
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 1.29e-06 | 2 | 40 | 2 | 6978711 | |
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 1.29e-06 | 2 | 40 | 2 | 6950384 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 1.29e-06 | 2 | 40 | 2 | 2997024 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 35898513 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 33353966 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 3008092 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 8660986 | ||
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 1.29e-06 | 2 | 40 | 2 | 3624865 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 28873507 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 1.29e-06 | 2 | 40 | 2 | 8428773 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 21857912 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 6609966 | ||
| Pubmed | Heterogeneity and linkage of equine C4 and steroid 21-hydroxylase genes. | 1.29e-06 | 2 | 40 | 2 | 2900855 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 24638111 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 1.29e-06 | 2 | 40 | 2 | 4514997 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 276882 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 1.29e-06 | 2 | 40 | 2 | 21345967 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 1.29e-06 | 2 | 40 | 2 | 5919331 | |
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 1.29e-06 | 2 | 40 | 2 | 6832377 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 1.29e-06 | 2 | 40 | 2 | 3167981 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 3794341 | ||
| Pubmed | Complement and c4 null alleles in severe chronic adult periodontitis. | 1.29e-06 | 2 | 40 | 2 | 17257223 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 2272665 | ||
| Pubmed | Multiple C4/Slp genes distinguished by expression after transfection. | 1.29e-06 | 2 | 40 | 2 | 3023818 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 7545960 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 30041577 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 2572548 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 22785613 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 2302180 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 1.29e-06 | 2 | 40 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 1.29e-06 | 2 | 40 | 2 | 34358307 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 32691186 | ||
| Pubmed | Genetic deficiency in complement component 4b does not alter radiation-induced lung disease in mice. | 1.29e-06 | 2 | 40 | 2 | 23259761 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 1.29e-06 | 2 | 40 | 2 | 18360261 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 1.29e-06 | 2 | 40 | 2 | 18091514 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 29080553 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 11168010 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 1.29e-06 | 2 | 40 | 2 | 8390682 | |
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 1.29e-06 | 2 | 40 | 2 | 26814963 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 6589636 | ||
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 1.29e-06 | 2 | 40 | 2 | 3902619 | |
| Pubmed | Genetic polymorphism of murine C3 controlled by a single co-dominant locus on chromosome 17. | 3.87e-06 | 3 | 40 | 2 | 681746 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 7.68e-05 | 9 | 27 | 2 | 1234 | |
| GeneFamily | PHD finger proteins | 3.20e-04 | 90 | 27 | 3 | 88 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.17e-03 | 34 | 27 | 2 | 487 | |
| GeneFamily | Complement system|Sushi domain containing | 1.31e-03 | 36 | 27 | 2 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 1.38e-03 | 37 | 27 | 2 | 454 | |
| GeneFamily | AAA ATPases|Mitochondrial respiratory chain complex assembly factors | 1.62e-03 | 40 | 27 | 2 | 645 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.76e-02 | 206 | 27 | 2 | 682 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 161 | 40 | 4 | c54010d88f1ecb6e0235bb66084876a4d5bf1ecd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 170 | 40 | 4 | be2a34c70665d8d11332b1a70eda03d77cb7f7dd | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-05 | 172 | 40 | 4 | 3a37569a5902f3c65ff8d3912421309a8c82ee9b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-05 | 172 | 40 | 4 | cc9d9dae290f11f8c348c78228af4e49469dc93b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.07e-05 | 181 | 40 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.05e-05 | 200 | 40 | 4 | a4c41509ca936e137230a6ae548c90f18a566d12 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 3.05e-05 | 200 | 40 | 4 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec | |
| Drug | Homocysteine | 1.10e-06 | 195 | 40 | 6 | ctd:D006710 | |
| Drug | 2-aminothiophenol | 9.02e-06 | 3 | 40 | 2 | ctd:C005464 | |
| Drug | xanthoxyletin | 1.80e-05 | 4 | 40 | 2 | CID000066548 | |
| Drug | robustaflavone | 1.80e-05 | 4 | 40 | 2 | CID005281694 | |
| Drug | C070379 | 2.49e-05 | 199 | 40 | 5 | CID003034747 | |
| Drug | ChAG | 3.00e-05 | 5 | 40 | 2 | CID000126253 | |
| Drug | Co K | 4.49e-05 | 6 | 40 | 2 | CID006852202 | |
| Disease | Mitochondrial Diseases | 4.07e-05 | 49 | 40 | 3 | C0751651 | |
| Disease | autism spectrum disorder (is_implicated_in) | 2.12e-04 | 16 | 40 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 4.27e-04 | 108 | 40 | 3 | DOID:684 (biomarker_via_orthology) | |
| Disease | Intrahepatic Cholangiocarcinoma | 4.85e-04 | 24 | 40 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 4.85e-04 | 24 | 40 | 2 | C3805278 | |
| Disease | Cholangiocarcinoma | 5.70e-04 | 26 | 40 | 2 | C0206698 | |
| Disease | MITOCHONDRIAL COMPLEX I DEFICIENCY | 7.61e-04 | 30 | 40 | 2 | C1838979 | |
| Disease | Parkinson's disease (biomarker_via_orthology) | 7.61e-04 | 30 | 40 | 2 | DOID:14330 (biomarker_via_orthology) | |
| Disease | Complement deficiency disease | 9.21e-04 | 33 | 40 | 2 | C0272242 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.26e-03 | 157 | 40 | 3 | DOID:14330 (implicated_via_orthology) | |
| Disease | Graves' disease (is_implicated_in) | 1.29e-03 | 39 | 40 | 2 | DOID:12361 (is_implicated_in) | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 1.56e-03 | 43 | 40 | 2 | DOID:9074 (implicated_via_orthology) | |
| Disease | left ventricular diastolic function measurement | 2.45e-03 | 54 | 40 | 2 | EFO_0008204 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MTQNERYKAAMRRAF | 71 | Q99424 | |
| QRMMIAEAYQSMYGR | 51 | Q9UJ72 | |
| YYMILSRGQIVFMNR | 506 | P0C0L5 | |
| GFNYKQMMVRDERRF | 146 | O43852 | |
| FRRRGKEMVDYMANY | 6 | P20711 | |
| SYGRISIMQFFNYVM | 151 | Q969Q6 | |
| ESFMKYMQNEYRSRG | 441 | P35228 | |
| KLMNFMYFQRNAIER | 121 | Q7L576 | |
| KGNRMDYYNALNLYM | 276 | O94952 | |
| LYESQNRGVYMFRMD | 4816 | Q8NEZ4 | |
| KANPVNRYMYVMDTR | 226 | Q9Y217 | |
| MPNYKLTYFNMRGRA | 1 | O60760 | |
| NMMQDYVRTGTYQRA | 161 | Q86X55 | |
| MASFVRQLNMYGFRK | 66 | Q00613 | |
| MQSLRDGNYYACKQM | 21 | Q9UQ07 | |
| TADFVNYYFERNMRM | 616 | O94880 | |
| NDMFVRTYGMLYMQN | 121 | Q9Y625 | |
| RTYGMLYMQNSEVFQ | 126 | Q9Y625 | |
| QKGTEMSMSQFVRYY | 146 | Q8NHM5 | |
| FMDRGYVFKMVNNYI | 1066 | Q96BY6 | |
| LRAIMNYQYGFNLVM | 231 | Q8IVF7 | |
| QRTNQMYSYFMFTRG | 231 | Q9Y375 | |
| EENFRYNNYKRTMMS | 1261 | Q9P267 | |
| MTFFQNSRYQTYQRM | 676 | Q16099 | |
| YYMILSRGQIVFMNR | 506 | P0C0L4 | |
| VTYMNMTAYNKGRLQ | 206 | Q8N7P1 | |
| FRQNEFMYYKMREAA | 451 | Q8NB12 | |
| FMYYKMREAALNNQP | 456 | Q8NB12 | |
| QEYGYDQSMMARFCR | 2221 | Q7Z333 | |
| AMIYVYNRGMNEFIS | 681 | Q8N3P4 | |
| YNMGFLFAYSMRQKT | 466 | Q96SZ6 | |
| RKMFCQYDSRGMSFN | 136 | Q06732 | |
| MLQVMENGRFAKYKY | 3061 | Q96RL7 | |
| QAMYIDSYNSRGFMI | 56 | Q9BU61 | |
| YMNQAMLFGRNPRYE | 481 | Q9BSA4 | |
| DNMVSYYHFQRMNKA | 141 | O75897 | |
| KNAFDYFNNMRMKYN | 541 | Q5JSH3 | |
| YFNNMRMKYNTEGRV | 546 | Q5JSH3 | |
| TYKSVQMMRQYNSFN | 206 | P48594 | |
| AAYFRQAENGMYIRM | 2201 | P27708 | |
| FVMNAGMRKYFLQAN | 81 | Q9HB21 | |
| KYVQMMGGRVYRDLN | 126 | Q92547 | |
| YKYQQQLSRAMRMYE | 476 | A6NCI4 | |
| MGMYKIILNQTARYF | 61 | Q6P5S2 |